A Prelude to Image Evolution

The point of disease intervention has rapidly moved forward with the advent of nanotechnology. Molecular and cellular interactions previously undetected are now visible to the diagnosing clinician.

An alternative to imaging to locate a tumor mass, nanotechnology is fueling the ability to detect clusters of changing cells at a molecular level. Detection at the earliest stages of disease allows timely intervention preventing onset and progression of clinical symptoms.

In combination with leading therapies, AION's products have the ability to provide patients and clinicians with the next generation of healthcare.

Detect. Prevent. Maintain.